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Renal phenotype of low kallikrein rats. coupled kinin B1 and B2 receptors mediates a broad spec-
Background. Renal kallikrein has been linked with inheri- trum of biological effects, including renal vasodilation,
tance of arterial hypertension and with sensitivity to drug neph- diuresis, and natriuresis [2, 3]. In the Utah study, urinaryrotoxicity. Identification of a cause–effect relationship between
kallikrein was found to be primarily influenced by ge-low kallikrein and intermediate phenotypes has been ham-
netic factors, with 51% of the total variance being causedpered by the lack of adequate animal models.
Methods. Kallikrein was measured in tissues obtained from by a single gene [4]. Reduced urinary kallikrein excretion
rats inbred for low urinary kallikrein excretion (LKR) and was reported in genetically hypertensive rats, and cose-
wild-type controls. Blood pressure and indices of myocardial gregation of a kallikrein gene polymorphism with high
contractility were recorded via an intraventricular cannula con-
blood pressure was recognized by crossing spontaneouslynected to a transducer. The functional relevance of endogenous
hypertensive (SHR) with normotensive Brown Norwayangiotensin II (Ang II) in LKR was explored by determining
rats [5–7]. Low urinary kallikrein phenotype is regardedthe effect of Ang II subtype 1 (AT1) receptor blockade on
glomerular filtration rate, renal blood flow, and urinary sodium as an indicator of blood pressure sensitivity to salt in
excretion. In addition, sensitivity to gentamycin-induced neph- humans [8]. Susceptibility to develop hypertension with
rotoxicity was evaluated. an introduction of high salt intake was documented in
Results. Kallikrein activity was reduced by 60% in the kid-
knockout mice lacking the bradykinin B2 receptor geneney of LKR (P , 0.01), whereas it was increased in the heart
[9, 10], thus suggesting that a defective kallikrein-kinin(P , 0.05) and was unaltered in the pancreas, liver, and salivary
glands. Heart rate and myocardial contractility were reduced, system may sensitize these animals to the deleterious
and the mean blood pressure (MBP) was increased in LKR as cardiovascular effects of high sodium.
compared with controls (P , 0.05). LKR exhibited polydipsia, Besides being genetically determined, the kallikrein
polyuria, glomerular hyperfiltration, and reduced fractional so- phenotype appears to be influenced by common environ-dium excretion under basal conditions and impaired renal vaso-
mental factors, as suggested by a strong spouse–spousedilation in response to volume expansion. These functional
correlation. Dietary potassium was indicated as the ma-alterations were significantly attenuated by AT1 receptor block-
ade. Gentamycin reduced the glomerular filtration rate in LKR, jor factor responsible for noninherited variance [11, 12].
but not in controls. This interaction may be instrumental to the antihyper-
Conclusions. In LKR, unopposed activity of Ang II appears tensive action of dietary potassium supplementation in
to be responsible for increased glomerular hydrostatic pressure
essential hypertensives [13–15] or young SHR [16]. Re-and augmented tubular reabsorption. Balance between the kal-
cently, the beneficial properties of kallikrein have beenlikrein-kinin and renin-angiotensin systems is essential for nor-
extended to include renal protection and repair. In fact,mal renal function.
administration of tissue kallikrein in the form of purified
protein or by the way of adenovirus-mediated gene trans-
fer reportedly exerts renal protection in Dahl salt-sensi-The serine proteinase tissue kallikrein (EC 3.4.21.35)
tive rats, two-kidney, one-clip Goldblatt hypertensivecleaves low molecular weight kininogen to release the
rats, and gentamycin nephrotoxic rats [17–19].vasoactive kinin peptide [1]. Activation of G-protein–
In the past years, a strain was developed in our labora-
tory by breeding rats from a Wistar stock according to
low urinary kallikrein levels, exclusively [20]. Low-kalli-Key words: blood pressure, glomerular filtration rate, renal blood flow,
kinins, arterial hypertension. krein rats (LKRs) develop mild-to-moderate blood pres-
sure elevation when exposed to high dietary sodium in-Received for publication August 9, 2000
take. Histologic abnormalities were detected at differentand in revised form December 22, 2000
Accepted for publication January 8, 2001 levels of the nephron, functionally related to the altered
renal phenotype. These alterations did not preclude cor-Ó 2001 by the International Society of Nephrology
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rection of salt sensitivity by exogenous kallikrein supple- tomidine chloridrate (0.4 mg/kg body weight) and were
mentation [21, 22]. LKR may offer a unique opportunity kept at 378C on a heating pad. Left intraventricular blood
for studying the influence of environmental factors on pressure and heart rate (HR) were measured with a
renal function in the context of an inherited defect in high precision transducer (World Precision Instruments,
renal kallikrein expression. Basile, Comerio, Italy) via a G22 needle inserted through
The present study focused on characterizing the car- the chest wall [24]. Data were collected on a four-channel
diac and renal phenotype of LKR and determining PowerMcLab polygraph and stored for subsequent com-
whether defective expression is restricted to the kidney. putation of left ventricular end diastolic pressure
We also evaluated whether functional abnormalities typ- (LVEDP) and maximal change in developed pressure
ical of this strain can be corrected by blockade of angio- (dP/dtmax). At the end of measurements, blood was sam-
tensin II subtype 1 (AT1) receptors. Finally, whether low pled for determination of hematocrit. The animals were
kallikrein sensitizes to gentamycin-induced nephrotoxic- then perfused with PBS at physiologic pressure via the
ity was evaluated. intraventricular needle. The heart, kidneys, submandibu-
lary glands, liver, and pancreas were harvested for deter-
mination of kallikrein activity in homogenates.METHODS
Male rats were housed at a constant room temperature Gentamycin-induced nephrotoxicity
(24 6 18C) and humidity (60 6 3%) with a 12-hour light/ Wistar rats and LKRs were randomly divided into
dark cycle. They had free access to rat chow (sodium, four groups (N 5 6 each). The first one was injected
0.12 mmol/g, Mucedola, Settimo Milanese, Italy) and tap
with sterile saline (2 mL/g body weight, subcutaneously).water, except in selected sets of experiments. All proce-
The other three groups received gentamycin sulfatedures complied with the standard for the care and use
(Sigma-Aldrich) at the doses of 20, 40, or 80 mg/kg bodyof animals, as stated in the Guide for the Care and Use
weight in saline for ten consecutive days. Twenty-four–of Laboratory Animals (Institute of Laboratory Animal
hour urine collections were obtained on day 10, with theResources, National Academy of Science, Bethesda,
rats deprived of food to avoid urine contamination. Uri-MD, USA).
nary volume (UV) was calculated gravimetrically, and
samples were used for analysis of urinary sodium (UNa),Immunohistochemical localization of renal kallikrein
kallikrein (UKall), creatinine (UCr), protein (UProt), and N-Anesthetized Wistar rats and LKRs (N 5 5 and 6,
acetyl-b-D-glucosaminidase (UNAG). In addition, bloodrespectively) were perfused at physiologic pressure with
was sampled via a small incision of the tail for determina-phosphate-buffered saline (PBS), followed by buffered
tion of plasma creatinine (PCr). The animals were thenparaformaldehyde (pH 7.4). Kidneys were harvested and
weighed and sacrificed. Both kidneys and the heart werefixed in buffered paraformaldehyde for 24 hours at room
harvested, cleaned, washed in saline, blotted, weighed,temperature. The samples were then dehydrated in etha-
fixed in buffered formaldehyde solution, and paraffinnol and embedded in paraffin. Renal sections (5 mm)
embedded. Kidney sections, stained with hematoxylinwere cut and incubated overnight at 228C with an anti-
and eosin, were analyzed using light microscopy.body raised against rat tissue kallikrein [23]. At variance
with the antiserum used in a previous study [22], this Characterization of renal function under basal
antibody does not cross-react with esterase A. Then, a conditions and following AT1 receptor blockade orsecond antibody (swine anti-rabbit IgG; Dako, Carpin- volume expansion
teria, CA, USA) at a dilution of 1:80, and peroxidase/
Blood (0.5 mL) was obtained from unanesthetized ratsantiperoxidase complex (Dako) at 1:100 was applied for
of each strain (N 5 6 per group) through an incision of30 minutes each. The peroxidase activity was visualized
the tail for measurement of plasma renin activity (PRA).by incubating the sections in a 0.1 (wt/vol) of 3,39-diami-
The following day, measurements of urine flow rate,nobenzidine (Sigma-Aldrich, St. Louis, MO, USA) and
glomerular filtration rate (GFR), and renal blood flow0.03% (vol/vol) H2O2 solution for 15 minutes in the dark.
(RBF) were performed with animals anesthetized andControls were prepared by omission of the first antibody
placed on a heating pad at 378C [19]. Infusion of inulinand replacement by nonimmune rabbit serum at the
and para-aminohippuric acid (PAH) was performed viasame dilutions. Three sections were examined for each
a cannula inserted into the left femoral vein, while mea-animal. Tubular cells were counted in each field, using
surement of blood pressure and a blood sampling werea square ocular grid, to compute cell density.
made via a catheter inserted into the left femoral artery.
Left ventricle performance and kallikrein activity in The bladder was cannulated for urine collection. Forty-
various tissues five minutes were allowed for the preparation to reach a
steady state. Two timed urine collections were obtained,Wistar rats and LKRs (3 or 6 months of age, N 5 6
with blood (0.6 mL) collected at the end of each clear-each group) were anesthetized with an intramuscular
injection of ketamine (20 mg/kg body weight) and mede- ance period. GFR and renal plasma flow were deter-
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mined from the clearance of inulin and PAH, respec- grouping factor. In multiple comparisons among inde-
tively, and were normalized to kidney weight. pendent groups in which ANOVA and F test indicated
In separate experiments, 24-hour urine collections significant differences, the statistical value was deter-
were obtained, as specified previously in this article. At mined according to the Bonferroni’s method. Differ-
the end of collection, the animals were allowed to return ences within or between groups were determined using
to their cages with free access to food. The following day, the paired or unpaired Student t test, respectively. A
rats were intraperitoneally injected with the nonpeptidic value of P , 0.05 was interpreted to denote statistical
AT1 antagonist A-81988 [2-(N-propyl-N-29(1H-tetrazol- significance.
5yl)biphanyl-4-yl)methyl amino pyridine-3-carboxylic
acid] at 1.7 mg/kg body weight in 100 mL sterile saline
RESULTS[25]. One hour later, the animals were placed in meta-
Cardiovascular phenotype of LKRbolic cages for urine collection. Blood was withdrawn
at the end of this 24-hour collection according to the As indicated in Table 1, LKRs showed reduced body
procedure indicated previously in this article. weight gain from three to six months of age compared
In additional studies, rats (N 5 10 per group) were with controls (P , 0.05). Heart weight normalized by
anesthetized and instrumented with a jugular catheter body weight was higher in LKR at three months, but
for drug infusion and a femoral artery catheter for con- not at six months.
tinuous measurement of mean blood pressure (MBP) The HR of anesthetized LKR was significantly lower
using a transducer connected to a Power McLab poly- at both ages examined as compared with wild-type con-
graph. In addition, a Doppler flowmeter probe was posi- trols, this bradycardia being associated with reduced left
tioned on the left renal artery through an incision of the ventricular contractility index, dP/dtmax (P , 0.05 for both
abdominal wall for measurement of red cell velocity, an comparisons). Systolic blood pressure and LVEDP did
index of renal blood flow (RBF) [26]. After a ten-minute not differ between strains. In contrast, MBP was mod-
stabilization period, the AT1 antagonist A-81988 (5 mg/kg estly but significantly increased in LKR (82 6 2 vs. 71 6
body weight in 100 mL saline) was injected intravenously, 3 mm Hg in controls at 3 months, P , 0.05).
and hemodynamic parameters were recorded for an ad-
ditional 10 minutes. Kallikrein activity in tissue homogenates
To test the effects of acute volume expansion, anesthe- As shown in Figure 1, in three-month-old LKR, renal
tized rats (N 5 7 per group) were infused with saline kallikrein activity was reduced by 60% compared with
(5% body weight) intravenously over three minutes [27]. controls (P , 0.01). In the same animals, kallikrein was
MBP and Doppler RBF were continuously recorded un-
increased in the heart (P , 0.05) and was unchanged inder basal conditions and for 30 minutes following saline.
the pancreas, liver, and submandibulary glands (P 5 NS).
Concentration test
Immunohistochemical localization of renal kallikrein
In Wistar rats and LKRs (N 5 5 per group), concentra-
Kallikrein immunoreactivity was restricted to connect-tion ability was evaluated by determining UV and osmo-
ing tubules without any staining in proximal or otherlarity (UOsm) before and after water deprivation. To this
cortical or medullary tubules. As shown in Figure 2,aim, 24-hour urine collections were obtained under basal
there was a striking difference between strains. In LKR,conditions and then starting 18 hours after water with-
faint staining was observed, with kallikrein mostly lo-drawal.
cated at the periphery of the connecting tubular cells.
Kallikrein-positive cells were reduced in terms of densityBiochemical assays
or percentage of total cortical tubular cells (175 6 9 vs.Plasma renin activity was measured by radioimmuno-
386 6 26 cells per 0.16 mm2 in controls and 9.6 6 2.9 vs.assay. Inulin and PAH concentrations were determined
20.7 6 1.2% in controls, P , 0.01 for both comparisons),by anthrone and colorimetric methods, respectively. Uri-
while no group difference was detected in tubular cellnary kallikrein activity was measured in urine and tissue
size (112 6 2 vs. 111 6 6 mm2, P 5 NS). In addition,homogenates by an amidolytic assay, as previously de-
LKR exhibited tubule lumen dilation.scribed [20]. UNAG levels were determined using a colori-
metric assay [20]. Sodium concentration was determined
Gentamycin nephrotoxicityby flame photometry. PCr, UCr, and UOsm were measured
As shown in Table 2, vehicle-treated LKR showedwith an autoanalyzer.
elevated UV and GFR and reduced fractional sodium
Statistical analysis excretion (FENa) compared with controls (P , 0.05).
Gentamycin dose dependently reduced GFR in LKRAll results are expressed as mean 6 SEM. Multivariate
(P , 0.05) only. The latter effect was associated with arepeated-measures analysis of variance (ANOVA) was
performed to test for interaction between time and significant increase in FENa.
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Table 1. Hemodynamic characteristics of low kallikrein rats (LKR)
Wistar rats LKR
Age months 3 6 3 6
Body weight g 286612 488630 32168 41969a
Heart wt g/100 g body weight 0.2760.01 0.2460.01 0.3060.01a 0.2660.01
SBP mm Hg 11863 12062 11963 12262
MBP mm Hg 7163 72 63 8262a 8462a
HR beats/min 263610 232620 19969a 173618a
dP/dtmax mm Hg/sec 53966152 60016229 40706392a 39526674a
LVEDP mm Hg 7.260.7 6.362.8 6.461.7 8.362.0
Values are mean 6 SEM. Abbreviations are: SBP, systolic blood pressure; MBP, mean blood pressure; HR, heart rate; dP/dtmax, maximal change in developed
pressure; LVEDP, left ventricular end diastolic pressure.
a P , 0.05 vs. Wistar rats of the same age
kidney weight or kidney-to-body weight ratio within ve-
hicle treatment. Gentamycin treatment resulted in simi-
lar increases in kidney weight in both strains. Renal
sections of gentamycin-treated rats showed histologic
alterations, mainly consisting of tubular dilation and
damage with necrotic cells filling proximal tubule lumen
(data not shown). These morphologic alterations were
quantitatively similar in LKRs and controls.
The heart-to-body weight ratio was higher (P , 0.05)
in vehicle-treated LKRs (0.32 6 0.02 g/100 g body
weight) as compared with controls (0.25 6 0.01 g/100 g
body weight), and this difference was maintained in rats
given gentamycin (0.28 6 0.05 vs. 0.24 6 0.01 g/100 g
body weight in controls, P , 0.05).
Characterization of renal function under basal
conditions and following AT1 receptor blockade or
volume expansion
Functional studies performed with rats under the ef-
fects of anesthesia showed significantly higher inulin clear-
ance in LKR (0.42 6 0.05 vs. 0.33 6 0.03 mL/min/g kidney
weight in controls, P , 0.05), whereas the clearance of
PAH did not differ between groups (data not shown).
Plasma renin activity was significantly lower (P , 0.05)
in unanesthetized LKRs (10.75 6 4.28 ng/mL/h) as com-
Fig. 1. Kallikrein activity in tissue homogenates of normal Wistar rats
pared with controls (27.84 6 3.89 ng/mL/h). Pharmaco-(h) and low kallikrein rats (LKR; j). Kallikrein activity was reduced
logical studies were performed to evaluate the functionalin kidney and was increased in heart of LKR. Data are means 6 SEM
(N 5 6). 1P , 0.05 vs. Wistar rats. relevance of endogenous angtiotensin II (Ang II) in this
model. As shown in Figure 4, AT1 receptor blockade
significantly reduced the polydipsia and polyuria typical
of LKRs (P , 0.05). These effects were associated with
The UKallV was not affected by vehicle, whereas it abrogation of glomerular hyperfiltration, as documented
was dose dependently decreased by gentamycin in both by measurements of the clearance of endogenous creati-
strains (P , 0.05; Table 2 and Fig. 3), with LKRs showing nine, and with a reduction in UNAGV. UNaV and FENA
lower kallikrein levels for each dose tested (P , 0.01). were increased by AT1 receptor blockade in LKR (from
The UNAGV was elevated in vehicle-treated LKRs com- 0.50 6 0.17 to 1.01 6 0.07 mmol/day and from 0.07 6
pared with controls (P , 0.05). Following gentamycin, 0.01 to 0.21 6 0.03%, P , 0.01 for both comparisons),
enzymuria was similarly augmented in both strains. The whereas these parameters remained unchanged in con-
highest dose of gentamycin increased UProtV (from 12 6 5 trols (from 0.34 6 0.07 to 0.31 6 0.07 mmol/day and from
to 42 6 3 mg/day in LKR and from 10 6 6 to 41 6 4 mg/ 0.09 6 0.01 to 0.09 6 0.01%, P 5 NS). The difference in
day in controls, P , 0.05 for both comparisons). UKallV between strains remained unchanged following
Ang II antagonism.No strain-related difference was observed regarding
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Fig. 2. Histologic sections of kidneys from Wistar rat and low kallikrein rat (LKR), stained with antibody against rat kallikrein (3120 magnifications).
Control Wistar rat (B) illustrating typical normal staining of distal tubular cells positive for kallikrein (arrow). (A) LKRs illustrating the faint
staining of tubular cells (arrow); tubular dilation is also shown.
Table 2. Effects of gentamycin on renal function and urinary kallikrein excretion
Wistar rats LKR
Gentamycin mg 0 20 40 80 0 20 40 80
Body weight g 32169 362630 324619 291621a 338610 368625 351625 309623a
UV mL/day 2167 28 64 2364 3165 6164b 5563b 4464b 54612b
GFR mL/min/g 0.7660.04 0.6760.08 0.5760.07 0.6260.06 1.4960.03b 0.9560.05bc 0.8660.08bc 0.7360.1c
UNaV mmol/day 0.4660.14 0.5960.13 0.5160.12 0.3360.17 0.5660.20 0.9260.11 0.9460.14 0.4660.11
FENa % 0.1360.02 0.1660.20 0.1560.02 0.0860.01 0.0860.01b 0.1560.02c 0.1960.02c 0.0960.01
UKall V nkaal/g cr 942671 223654c 105635c 51611c 318654b 5768bc 51610bc 26610bc
UNAGV U/day 233661 837670c 9696214c 8166290c 370668b 284628b 684676c 8266204c
Hematocrit % 44.961.4 49.562.4 45.063.3 54.763.3c 60.362.2b 52.061.4c 49.761.3c 53.762.4c
Kidney weight g/100 g 0.3660.02 0.3860.01 0.4660.03c 0.5660.06c 0.3960.01 0.4260.01 0.4160.02 0.5860.05c
Values are mean 6 SEM. Abbreviations are in Table 1 and: UV, urinary volume; GFR, glomerular filtration rate; UNaV, urinary sodium volume; FENa, fractional
excretion of sodium; UKallV, urinary kallikrein volume; UNAGV, urinary N-acetyl-b-D-glucosaminidase volume.
P , 0.05: a vs. Basal, b vs. Wistar rats, c vs. Vehicle
As shown in Figure 5 A–C, acute blockade of the AT1
receptor resulted in a more pronounced blood pressure-
lowering effect in LKRs (P , 0.05). In addition, renal
vasodilation was observed in both groups, with this effect
occurring more promptly in LKRs.
As shown in Figure 5 D–F, acute volume expansion
caused a modest decrease in MBP in controls (P , 0.05),
but not in LKRs. In controls, a decrease in renal vascular
resistance (RVR) occurred during the first six minutes
following volume expansion (P , 0.05), whereas no sig-
nificant change was detected in LKRs (P 5 NS).
Renal concentration ability
As shown in Figure 6, water deprivation revealed the
integrity of the concentration mechanisms in both strains.
DISCUSSION
Genetically engineered animal models have been gen-
erated that lack single components of the kallikrein-kinin
system. Kininogen-deficient rats and kallikrein or kinin
B2 receptor knockout mice exhibit distinct cardiovascular
alterations, namely blood pressure sensitivity to salt [28]
and dilative left ventricular remodeling with aging (ab-
stract; Meneton et al, Hypertension 34:333, 1999) [24].
Information gained from this strategy has widened our
knowledge on the physiological relevance of the kalli-
krein-kinin system in cardiovascular function. However,
the term “model” should be cautiously used to denote
similarity with human disease states, inasmuch as a total
deficiency of any component of the kallikrein-kinin sys-
tem has never been described in humans. Furthermore,
indiscriminate abrogation of expression achieved by gene
disruption in a germline substantially differs from the
defect observed in hypertensive patients, which consists
of a reduced urinary output of the enzyme. In this con-
text, the LKR strain represents a more appropriate
model to reproduce the functional impact than an inher-
ited defect in renal kallikrein might have in humans.
In LKRs, kallikrein expression was not universally
depressed in all tissues examined: Enzyme activity was
reduced at kidney level, increased in the heart, and un-
changed in the pancreas, liver, and submandibulary
glands. Within the kidney, kallikrein immunoreactivity
was restricted to the distal tubule, a result consistent
with other immunocytochemistry reports [2]. Using im-
munoistochemical analysis, we have documented a re-
duced numerical density of kallikrein-positive tubular
cells in renal sections of LKR. However, at variance with
our earlier studies [22], the faint immunoreactive signal
b
Fig. 3. Urinary kallikrein activity in normal Wistar rats (A) and LKR
(B) under basal conditions (h) and after gentamycin (j) or vehicle ( ).
Gentamycin administration reduced urinary kallikrein in both strains.
Data are means 6 SEM (N 5 6 each group). 1P , 0.05 vs. basal.
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Fig. 4. Effect of angiotensin II subtype 1 (AT1) receptor blockade on renal function in normal Wistar rats (s) or LKR (d). LKR showed
polydipsia, polyuria, glomerular hyperfiltration, and increased enzymuria under basal conditions, with these alterations being partially corrected
by AT1 receptor blockade. In addition, fractional sodium excretion was increased by AT1 receptor blockade in LKRs (data shown in the Results
section). Data are means 6 SEM (N 5 6 each group). 1P , 0.05 vs. control; §P , 0.05 vs. basal.
detected at the level of distal tubule of LKR was not Blood pressure is reportedly increased in conscious
LKR [22]. Our current study consistently shows in-associated with any increase of staining in proximal tu-
bules. This discrepancy may be explained with the fact creased MBP levels in LKRs under the effects of anes-
thesia. In the same animals, myocardial contractility wasthat in contrast to the antiserum used earlier [22], the
antibody employed here does not cross-react with ester- apparently depressed as indicated by reduced dP/dtmax.
However, the bradycardia observed in these animals mayase A. It remains unknown whether an increase in ester-
ase A, a member of kallikrein multigene family, may have influenced the MBP parameter. Further studies
are necessary to address the possible development ofrepresent a compensatory response to the reduction in
renal kallikrein synthesis. myocardial remodeling and dysfunction in LKRs, and
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Fig. 6. Effects of water deprivation on UV (A) and osmolality (B) in
normal Wistar rats (s) or LKR (d). Water deprivation revealed intact
urinary concentrating mechanisms in LKR. Data are means 6 SEM.
1P , 0.05 vs. control; §P , 0.05 vs. basal.
c
to recognize the relevance of the differential kallikrein
expression pattern in the heart and kidney.
Compared our previous studies [22], we found that
further inbreeding of the LKR results in additional phe-
notypical features, namely polydipsia, polyuria, and in-
creased GFR. Polyuria apparently occurs in spite of in-
tact urinary concentrating mechanism, suggesting that
the antidiuretic hormone (ADH) system is functioning
properly in these rats. Since the high urinary output was
not affected by maneuvers that decrease GFR, that is,
gentamicin nephrotoxicity, it appears unlikely that poly-
uria is the consequence of a primary impairment in glo-
merulotubular balance. Instead, it may be that these rats
have a central disturbance in water drinking.
The present data, especially those regarding baseline
hematocrit and poor weight gain, suggest the presence
of extracellular fluid volume contraction and hemo-
concentration in the LKR. Under these conditions, one
could envision that preservation of GFR may be possible
only as a consequence of activating counter-regulatory
systems. We hypothesized that a defective renal kalli-
krein activity might leave Ang II unbalanced at the glo-
merular and tubular levels. In the present study, PRA
was found to be reduced in LKR. This result, unexpected
on the basis of postulated extracellular fluid volume con-
traction, may be compatible with the assumption that
kallikrein represents one of the pro-renin activating en-
zymes [29]. We also documented that the functional renal
responses to antagonism of endogenous Ang II were
enhanced in these rats. In fact, glomerular hyperfiltration
was normalized, and sodium excretion was significantly
increased by chronic blockade of AT1 receptors. En-
hanced renal vasodilation observed in LKRs in response
to acute AT1 receptor blockade also favors our theory.
Furthermore, altered renal hemodynamic response to
acute volume expansion in LKR resembles that observed
in animals with Ang II-mediated hypertension [27]. All
together, these results suggest that in the presence of de-
fective kallikrein activity, the kidney becomes more sen-
sitive to endogenous Ang II. It is noteworthy to remem-
ber that urinary kinin excretion is reportedly normal in
LKRs [22]. Although infusion of kallikrein corrects the
renal abnormalities, this action may be independent of
b
Fig. 5. Effect of acute AT1 receptor blockade (A–C) or intravenous volume loading (D–F) on systemic and renal hemodynamics in normal Wistar
rats (d) or LKR (s). For the AT1 blockade, LKRs showed a greater reduction in mean blood pressure (MBP) and a more rapid renal vasodilation
compared with controls (N 5 10 each group). For volume loading, LKR exhibited blunted systemic and renal vasodilatory response compared
with controls (N 5 7 each group). Data are means 6 SEM. 1P , 0.05 vs. control; §P , 0.05 vs. basal.
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tensive strain, in Textbook of Hypertension, edited by Swales JD,the kininogenase activity of kallikrein. Therefore, fur-
Oxford, Blackwell Scientific Publications, 1994, pp 457–461ther characterization of this rat model is required before 8. Ferri C, Bellini C, Carlomagno A, et al: Urinary kallikrein and
any conclusions can be made about the involvement of salt sensitivity in essential hypertensive males. Kidney Int 46:780–
788, 1994kinins in any functional changes. It would be worthwhile
9. Alfie ME, Yang XP, Hess F, Carretero OA: Salt-sensitive hyper-also to explore whether the hyperfiltration observed in tension in bradykinin B2 receptor knockout mice. Biochem Bio-
LKR exerts long-term consequences. It is tempting to phys Res Commun 224:625–630, 1996
10. Madeddu P, Varoni MV, Palomba D, et al: Cardiovascular pheno-predict that this condition may favor renal functional
type of a mouse strain with disruption of B2-receptor gene. Circula-deterioration with aging.
tion 96:3570–3578, 1997
Finally, we investigated the possibility that the low- 11. Hunt SC, Wu LL, Slattery ML, et al: Environmental determinants
of urinary kallikrein excretion. Am J Hypertens 6:226–233, 1993kallikrein phenotype may represent a marker of genta-
12. Hunt SC, Hasstedt SJ, Wu CC, Williams RR: A gene-environ-mycin nephrotoxicity. This is an important issue since
mental interaction between inferred genotype and potassium. Hy-
nephrotoxicity occurs in some 30% patients treated with pertension 22:161–168, 1993
gentamycin and represents a limiting factor for clinical 13. Valdes G, Vio CP, Montero J, Avenda O: Potassium supplemen-
tation lowers blood pressure and increases urinary kallikrein inusage. In the absence of pre-existing renal abnormalities,
essential hypertensives. J Hum Hypertens 5:91–96, 1991no biochemical test is available to predict the develop- 14. Fujita T, Hayashi I, Kumagai Y, et al: Early increases in renal
ment of renal damage. Gentamycin administration de- kallikrein secretion on administration of potassium or ATP-sensi-
tive potassium channel blockers in rats. Br J Pharmacol 128:1275–creased urinary kallikrein excretion in both strains and
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